Written by: Doug Camplejohn, CEO & Co-Founder, Coffee | Last updated: September 24, 2026
Key Takeaways
- MEDDIC qualification depends on verifiable buyer evidence for each element, not rep enthusiasm or assumptions.
- Real qualification evidence includes quantified metrics, named economic buyers with confirmed authority, written decision criteria, mapped processes, and documented champion actions.
- Deals that appear qualified on paper often fail verification when CRM fields contain vague statements instead of buyer statements or documents.
- AI-powered conversation intelligence can capture and log MEDDIC evidence from calls and emails automatically, which removes most manual data entry.
- Coffee captures MEDDIC evidence automatically and structures CRM updates so qualification becomes verifiable data instead of guesswork.
Turn qualification into verifiable CRM data
How This Guide Uses Real Deals To Show MEDDIC In The CRM
Each scenario below follows the same structure. You see the deal situation, what the rep learned for each MEDDIC element with the exact question asked, the CRM evidence that confirmed or contradicted it, and the qualification verdict. One scenario extends into MEDDPICC to cover the Paper Process element.
MEDDIC scores a deal against six evidence-based factors. Metrics are quantified business impact. The Economic Buyer is the person with budget authority. Decision Criteria are the documented evaluation rules. Decision Process is the mapped approval sequence. Identify Pain is the verified, specific business problem. Champion is the internal advocate with influence and motivation. Every element needs evidence from the buyer, not inference from the rep.
The framing that runs through every scenario is “What the rep heard vs. what the rep verified.” Heard means a rep’s recollection of a call. Verified means a CRM record backed by a transcript, an email, an org chart, or a document the buyer produced. Qualification theater describes a deal that looks qualified on paper while the evidence trail is incomplete or inferred instead of grounded in buyer statements.
What Counts As Real Qualification Evidence Vs. CRM Theater
Deal reviews hinge on a simple distinction. Many CRM fields contain unverified claims that feel promising but do not qualify a deal.
- “They love us” signals a social impression and says nothing about Champion strength.
- “Budget is approved” usually reflects a rep’s interpretation of what a mid-level contact said, not confirmed Economic Buyer authority.
- “They need this by Q3” describes a preference with no mapped approval steps, so it does not qualify as a Decision Process.
- “Improve efficiency” expresses a vague aspiration without a number or baseline, so it does not qualify as Metrics.
Real qualification evidence comes from what the buyer said directly, what the buyer produced in writing, or what an automated system captured from the interaction. A scoring rubric that labels each element as “Verified” when the buyer told you directly or you have it in writing, and “Asserted” when it rests on inference or a single friendly source, makes this distinction operational.
The table in the disqualification scenario below contrasts what the rep heard with what the rep verified. The same logic applies to every deal in the pipeline.
What A MEDDIC-Qualified Deal Looks Like In The CRM
This baseline qualified deal sits in enterprise cybersecurity software. Deal size is $280,000 ARR with an expected close at the end of the current quarter. All six MEDDIC elements have evidence.
A fully qualified deal at this stage has six verifiable evidence items in the CRM. Each MEDDIC element ties to a specific buyer statement, document, or confirmed interaction instead of a rep’s interpretation. The rep can justify every element in a 60-second deal review without checking notes.
- Metrics: Quantified business impact confirmed by the buyer.
- Economic Buyer: Named, met, and confirmed budget authority.
- Decision Criteria: Documented evaluation framework received in writing.
- Decision Process: Mapped approval sequence with named owners and dates.
- Identify Pain: Specific, verified pain tied to a business consequence.
- Champion: Verified influence demonstrated through concrete advocacy actions.
Metrics
Question asked: “What specific business metrics are you trying to improve, and how will you measure the success of this initiative?”
Customer’s answer: “We had 14 mobile security incidents last year. Each one costs us roughly $180,000 in remediation and downtime. We need to get that below five incidents annually.”
CRM evidence: Call transcript logged. Metrics field populated: “14 incidents/year at $180K each; target: fewer than 5/year. Implied value: $1.62M risk reduction.” Economic impact confirmed by the VP of IT Security on a recorded call.
Economic Buyer
Question asked: “Who has final sign-off on this budget, and have you had a chance to discuss this initiative with them directly?”
Customer’s answer: “That’s our CISO, Dana Reyes. She’s already reviewed the business case. I can get you 30 minutes with her next week.”
CRM evidence: Meeting with Dana Reyes logged. Contact record created with title “CISO.” Post-meeting summary notes that Dana confirmed budget allocation from the security operations line item.
Decision Criteria
Question asked: “What criteria will you use to evaluate vendors, and what are the must-have versus nice-to-have requirements?”
Customer’s answer: “I’ll send you our RFP scoring matrix. Must-haves are real-time threat detection, SOC 2 Type II certification, and API integration with our SIEM. Everything else is weighted.”
CRM evidence: RFP scoring matrix attached to the opportunity record. Decision Criteria field: “Must-have: real-time detection, SOC 2 Type II, SIEM API. Weighted criteria documented in attached matrix.”
Decision Process
Question asked: “What steps are required to get this approved, and who needs to sign off at each stage?”
Customer’s answer: “Technical review by IT architecture this week, then a steering committee presentation on the 14th, then CISO sign-off, then procurement. We’ve done this before, and it usually takes three weeks end to end.”
CRM evidence: Decision Process field: “IT architecture review (week 1) → steering committee (14th) → CISO sign-off → procurement. Three-week timeline confirmed by champion.” Mutual Action Plan attached.
Identify Pain
Question asked: “What happens if you don’t solve this problem in the next 90 days?”
Customer’s answer: “We have a board audit in Q2. If we can’t show a credible mobile security posture, we risk losing our cyber insurance renewal. That’s a $4M exposure.”
CRM evidence: Pain field: “Board audit Q2; cyber insurance renewal at risk ($4M exposure if posture not demonstrated). Urgency confirmed by CISO in meeting on [date].”
Champion
Question asked: “Can you help me get time with Dana before the steering committee, and what objections do you expect the committee to raise?”
Customer’s answer: “Already done, I sent her the executive summary you gave me. The committee will push on integration complexity. I’ll prep them with the architecture diagram.”
CRM evidence: Champion field: “Marcus Chen, VP IT Security. Arranged CISO meeting unsolicited. Shared executive summary internally. Preparing committee objection responses. Influence verified.” Email thread attached.
Qualification verdict: Advance to Commit. Manager justification sentence: “Every MEDDIC element is evidenced by a buyer statement or document logged in the CRM. Metrics are quantified, the economic buyer is met and confirmed, decision criteria are in writing, the process is mapped, pain is tied to a board-level consequence, and the champion has demonstrated influence through concrete actions.”
See Coffee’s pipeline review tools
A MEDDIC Deal That Should Have Been Disqualified
The previous deal showed what full evidence looks like. This one shows the opposite. It entered the pipeline at $320,000 ARR in the enterprise HR software category, and the rep described it as “our strongest Q3 opportunity.” The champion sounded enthusiastic, the pain sounded urgent, and the budget sounded approved. Verification told a different story.
Metrics
Question asked: “What specific business metrics are you trying to improve, and what is the cost of not solving this problem?”
Customer’s answer: “We want to improve HR efficiency across the organization.”
CRM evidence: Metrics field: “Improve HR efficiency.” No number. No baseline. No cost of inaction. Vague answers like “improve efficiency” without numbers are a documented red flag for the Metrics element.
Economic Buyer
Question asked: “Who has final sign-off on this budget, and have you met with them to discuss this initiative?”
Customer’s answer: “That would be our CFO. She is aware of the project.”
CRM evidence: Economic Buyer field: “CFO, name unknown. Aware of project per champion.” No meeting logged. No contact record for the CFO. A common pitfall is spending months selling to an end-user who lacks purchasing authority.
Decision Criteria
Question asked: “What criteria will you use to evaluate vendors, and what are the must-have requirements?”
Customer’s answer: “Honestly, we just need something that integrates with Workday and is easy to use.”
CRM evidence: Decision Criteria field: “Workday integration, ease of use.” No formal evaluation framework. No scoring matrix. No written criteria received.
Decision Process
Question asked: “What steps are required to get this approved, and what is your typical timeline for purchases like this?”
Customer’s answer: “We’ll need to get a few people aligned. It shouldn’t take long.”
CRM evidence: Decision Process field: “A few people need to align, timeline TBD.” No named stakeholders. No approval sequence. No timeline. An unclear or constantly changing process with no defined timeline is a documented red flag.
Identify Pain
Question asked: “What happens if you don’t solve this problem in the next three to six months?”
Customer’s answer: “It would be a shame. We’ve been talking about this for a while.”
CRM evidence: Pain field: “Long-standing inefficiency, no urgency stated.” Evidence-based prompting should surface consequence and urgency, not just feature complaints. No business consequence. No deadline. No cost of inaction.
Champion
Question asked: “Can you get me 30 minutes with the CFO before we move to proposal stage?”
Customer’s answer: “She’s pretty hard to reach. I’ll try, but no promises.”
CRM evidence: Champion field: “Jordan Mills, HR Director. Enthusiastic. Cannot arrange CFO access.” A Champion who will not do something difficult for the seller does not function as a real Champion. No introductions made. No internal advocacy artifacts.
| MEDDIC Element | What the Rep Heard | What the Rep Verified |
|---|---|---|
| Metrics | “We want to improve HR efficiency” | No number, no baseline, no cost of inaction in CRM |
| Economic Buyer | “Budget is approved, CFO is aware” | CFO name unknown; no meeting logged; no contact record |
| Decision Criteria | “Workday integration and ease of use” | No written criteria; no scoring framework received |
| Decision Process | “Shouldn’t take long” | No named stakeholders; no approval sequence; no timeline |
| Identify Pain | “We’ve been talking about this for a while” | No urgency; no business consequence; no deadline |
| Champion | “They love us” | Cannot arrange economic buyer access; no advocacy artifacts |
Qualification verdict: Disqualify or downgrade to early-stage. This deal fails verification on all six elements. The correct action is to remove it from the commit forecast, return it to pipeline, and set a re-qualification condition: no advancement until the economic buyer is met and metrics are quantified.
A Competitive Deal Where Champion Influence Is Verified
Industry: B2B SaaS analytics. Deal size: $195,000 ARR. The rep entered the pipeline review confident and wrote: “Champion: Sarah Okonkwo, VP Data. Very supportive. Believes in the product.” The manager asked a simple follow-up: “What has she done to prove it?” The CRM showed no actions, no artifacts, and no evidence of influence.
Question asked to test champion strength: “What is your personal stake in getting this problem solved, and when you present this to the executive team, what are the top two objections you expect them to raise, and how can I help you prepare for them?”
Sarah’s response revealed the gap: “Honestly, I haven’t presented it to the exec team yet. I was hoping to get more information first.” She had not arranged a meeting with the CFO, who served as the economic buyer. She had not shared the business case internally. She also had not mentioned a competing internal initiative to build the capability in-house.
A coach likes you, while a champion spends their own credibility on you. Most “champions” function as coaches. Sarah fit the coach pattern.
The rep then asked: “Can you introduce me to your CFO, and can you share the org chart so I understand who else is involved in this decision?” Sarah agreed to try but could not commit to a timeline. Two weeks later, no introduction had been made.
CRM evidence after re-qualification: Champion field updated: “Sarah Okonkwo, VP Data, reclassified as Coach. Has not arranged EB access. Has not shared business case internally. Internal build-vs-buy initiative identified (not previously disclosed). No advocacy artifacts.” A competing internal initiative was logged as a risk factor.
Qualification verdict: At-risk. The deal remains in play because the pain and metrics are verified, but it cannot be forecast as committed until a true champion appears or Sarah demonstrates concrete advocacy. The manager’s justification sentence: “Champion influence remains assumed. No EB access. Internal competition surfaced only during re-qualification. Downgrade to pipeline pending champion re-assessment.”
A Deal At Risk From Paper Process And Procurement Timing
Industry: enterprise SaaS workforce planning. Deal size: $410,000 ARR. The rep marked it “Commit, 90% probability.” Five of six MEDDIC elements were green. The deal looked won, yet it was not forecastable.
The missing element was Paper Process, the MEDDPICC extension that maps what happens between verbal yes and signed contract. Paper-process delays kill more deals in the final stages than competitive losses do.
Question asked to expose the gap: “Last time you bought something like this, what took longer than you expected between the decision and the signed contract?”
The champion answered: “Oh, legal took forever. And IT security had a questionnaire that sat for six weeks because the analyst who owned it was on leave.”
CRM evidence (or absence of it): Paper Process field: blank. No security questionnaire status. No legal review owner named. No procurement contact identified. No timeline mapped. A blank “Procurement Contact” field on a late-stage opportunity usually means the rep has not identified who controls the timeline.
When the rep mapped the actual paper process, the picture changed. The IT security questionnaire alone would take about four weeks because its owner was on parental leave until the 20th. Legal redlines added two to three weeks, procurement portal vendor registration added one to two weeks, and internal sign-off added another week. The total timeline reached eight to ten weeks from verbal yes. Weak Paper Process qualification can lead to 60 to 120 day slips between verbal commitment and signature.
Qualification verdict: At-risk, not committed. The deal is real because pain, metrics, economic buyer, and champion are all verified. It still cannot close this quarter. The correct forecast entry is next quarter with a mapped paper process. The manager’s justification sentence: “Verbal yes is likely. Paper process maps to eight to ten weeks minimum. Current quarter close is not forecastable. Moving to next quarter pipeline with procurement milestones tracked.”
Map paper process directly from call notes
MEDDIC Results: What Companies Actually Reported
Those scenarios show what qualification looks like deal by deal. Zooming out, here is what companies report when they adopt the framework. These figures come from vendor-reported case studies, not independent research, and are attributed to named companies.
Organizations implementing MEDDIC consistently report 15-30% improvements in close rates and much better forecast accuracy, according to Fullcast’s 2026 MEDDIC guide. Unqualified pipelines carry 30-50% forecast errors, while teams implementing MEDDIC often bring that number below 10%, according to Gain.io’s analysis of MEDDIC implementation data cited by Fullcast.
Jose Angelo, founder of Jose Angelo Studios, reported that structuring a solution directly at a Fortune 500 technology client’s pain points using MEDDPICC led to a $400,000 deal within 45 days, about 60% faster than the typical sales cycle, and surfaced the economic buyer as the Chief Revenue Officer, which helped resolve a $2 million revenue leak.
Tyler Hull, founder and sales manager of Modern Exterior, reported that the Decision Criteria component of MEDDPICC helped the company close 15% more deals within six months, and that providing champions with personalized ROI breakdowns helped close 25% more deals because champions had the data needed to influence internal stakeholders effectively.
These MEDDIC results point in the same direction: higher win rates, larger deal sizes, and better forecast accuracy. The exact magnitude varies by team, deal complexity, and how strictly leaders enforce the process, so no figure should be treated as a guarantee.
How To Tell Real Qualification From CRM Theater
A Supered survey of 198 sales leaders found that 89 percent had a defined sales process, but only 36 percent saw their reps follow it. The gap between having MEDDIC fields and using them as evidence explains many forecast misses.
Reps often game MEDDPICC fields to satisfy managers. Common patterns include copying a vague phrase from a call into the Metrics field, naming a mid-level contact as the Economic Buyer without ever meeting them, and marking the Champion field green because the contact is friendly. Reps who must verify the economic buyer treat MEDDIC as real work, while reps who can advance deals without verification treat it as paperwork.
The compact evidence checklist above is the standard for every deal review. If a rep cannot produce the evidence item, that element remains unqualified regardless of what the CRM field says.
- Metrics: A specific number with baseline, target, and cost of inaction, stated by the buyer and logged from a call transcript or email.
- Economic Buyer: A named individual with a logged meeting and a confirmed statement of budget authority.
- Decision Criteria: A written document such as an RFP, scoring matrix, or email that the buyer produced.
- Decision Process: A mapped sequence with named owners, approval steps, and dates.
- Identify Pain: A specific business consequence with a dollar figure or deadline.
- Champion: At least one concrete advocacy action such as arranging a meeting, sharing an internal document, or warning about a competitor.
How Automated Activity Capture Changes MEDDIC Evidence In 2026
The scenarios above assume the CRM record reflects what actually happened in the deal. In most sales organizations, that assumption fails.
AI-powered conversation intelligence platforms can capture MEDDPICC criteria from sales calls automatically. When a prospect says procurement usually takes six to eight weeks, the platform logs that as Paper Process evidence and populates the CRM field. That work otherwise costs reps 20-30 minutes after every call.
When an autonomous agent captures emails, calendars, and call transcripts automatically, the CRM record becomes ground truth instead of a rep’s recollection. The “What the rep heard vs. what the rep verified” distinction narrows because the agent logs what the buyer said, verbatim, at the moment it was said.
Coffee’s agent handles this capture automatically. It joins calls, records and transcribes, generates post-call summaries, and structures notes according to BANT, MEDDIC, or SPICED. Deal reviews then rely on evidence that appears in the CRM without extra effort from the rep. When a prospect says “our CISO needs to sign off and legal usually takes three weeks,” that statement is logged, timestamped, and mapped to the correct MEDDIC element in the CRM. The rep does not need to remember it. The manager does not need to rely on the rep’s memory. The evidence sits in the record.
Coffee works as a standalone CRM for small to mid-sized businesses or as a companion app on top of existing Salesforce or HubSpot instances. It meets teams where they are without a rip-and-replace. Coffee also works with both structured and unstructured data, built on a data warehouse that preserves historical context instead of overwriting it.
Capture MEDDIC evidence automatically
How To Run A MEDDIC Deal Review: A Manager’s Framework
A MEDDIC deal review functions as a structured evidence review, not an interrogation. The manager reads the CRM record, separates verified elements from asserted ones, and asks the rep to produce evidence for any element marked green without a supporting artifact.
The framework for each deal in the review follows a simple sequence.
- Start by reading the MEDDIC fields before the meeting, because a blank or vague field highlights the coaching point.
- From there, ask the rep for the justification sentence: “Tell me in one sentence why this deal is in commit.” If the sentence includes phrases like “they love us,” “budget is approved,” or “should be fine,” ask for the evidence behind each claim.
- Next, test each element against the evidence checklist. For every element, ask: “What did the buyer say, and where is it logged?”
- Any element that remains asserted rather than verified gets a re-qualification action with a deadline before the next review.
- Finally, use Coffee’s Pipeline Compare feature to visualize week-over-week changes, including which deals progressed, which stalled, and which are new, without exporting spreadsheets. Deals with no activity logged in 10+ days sit at the top of the priority list in weekly pipeline reviews, alongside other deal-health signals such as declining coaching scores, single-threaded stakeholder engagement, and stalled stage progression.
The goal is to turn the pipeline review into a strategic discussion about which deals have the evidence to close and which need intervention. Deals are often won on the strength of the champion, slip on a missing decision process, and are lost on decision criteria nobody documented. The deal review is where leaders catch those gaps before they become forecast misses.
Frequently Asked Questions
Is MEDDIC Still Relevant Today?
MEDDIC and MEDDPICC remain the most referenced structured qualification methodologies for complex enterprise B2B sales in 2026, although they appear in only about 9% of executive sales job postings tracked by The CRO Report, while broader terms like Consultative Selling appear more often. Their relevance has increased in an AI-assisted sales era for two reasons. Buying groups have grown, and B2B buying groups now average 6-10 decision makers, which makes structured qualification of the economic buyer, decision process, and champion more important. AI-assisted activity capture also now populates MEDDIC fields from call transcripts and emails automatically, which removes much of the manual data entry burden that caused adoption failures in earlier implementations. The framework’s core logic of evidence over enthusiasm remains the same, while the infrastructure to enforce it has improved. MEDDIC deal review questions can now be answered from the CRM record instead of from a rep’s memory, which is the condition under which the framework delivers its full value.
Why Is MEDDIC Better Than BANT?
BANT (Budget, Authority, Need, Timeline) is a lighter framework suited to transactional sales with short cycles and single decision-makers. It breaks down in complex B2B deals because it treats budget as a binary state instead of mapping who controls it and under what conditions, and it does not require verification of authority through direct access to the economic buyer. A deal that passes BANT with “budget is approved, the contact has authority, they have a need, and they want it by Q3” can still fail every MEDDIC element. The disqualification scenario in this guide shows that pattern: BANT-positive, MEDDIC-negative, and a forecast miss waiting to happen. MEDDIC’s requirement to verify the economic buyer directly, map the decision process with named owners, and confirm champion influence through concrete actions catches gaps that BANT cannot see.
What Is The MEDDIC Sales Checklist?
The MEDDIC sales checklist is the compact evidence standard described earlier. For each of the six elements, there is one required evidence item: a quantified metric stated by the buyer, a named and met economic buyer with confirmed budget authority, a written decision criteria document produced by the buyer, a mapped decision process with named owners and dates, a specific pain tied to a business consequence, and at least one concrete champion advocacy action logged in the CRM. An element remains unqualified until the evidence item exists. The checklist fits on one screen with six lines and no ambiguity, which makes it practical in real deal reviews. Teams that enforce this standard as a stage-gate requirement, so a deal cannot advance without the evidence logged, report the largest improvements in forecast accuracy from MEDDIC adoption.
Conclusion: MEDDIC As Evidence, Not Enthusiasm
Every scenario in this guide returns to the same principle: MEDDIC treats qualification as evidence, not enthusiasm. The difference between a qualified deal and a forecast miss does not hinge on whether the rep believes in the opportunity. It hinges on whether the rep can produce verified evidence for each element from the CRM record. A champion who has not arranged a meeting behaves like a coach. A budget that appears “approved” without a named economic buyer behaves like a rumor. A decision process that sounds “straightforward” without mapped steps behaves like a guess.
The framework works when leaders insist on buyer-sourced evidence for every MEDDIC element and when that evidence lives in the CRM, not in a notebook. Automation now removes much of the logging burden, so teams can focus on real discovery instead of data entry. When you combine disciplined questioning, clear evidence standards, and automatic capture, MEDDIC turns from a checklist into a reliable way to decide which deals deserve your time and your forecast.
